Table 1 Demographic characteristics and clinical features (symptomatic and structural disease severity parameters) in our study population with AS

Age (yrs): m (SD)

40.7

(11.0)

18

66

Disease duration (yrs): m (SD)

9.3

(7.9)

1

36

BASDAI: m (SD)

3.7

(2.4)

0

8.6

BASMI: m (SD)

2.8

(5.5)

0

36

BASFI: m (SD)

40.5

(28.1)

0

83

BAS-G: m (SD)

17.5

(22.7)

0

72

ESR (mm/H): m (SD)

27.1

(21.0)

2

78

CRP (mg/l) : m (SD)

15.3

(25.1)

0.3

168.0

SASSS: m (SD)

10.7

(15.7)

0

72

Anti-TNF use : n (%)

22

(32.9)

Anti-TNF use duration (yrs): m (SD)

2.3

(1.7)

0.25

7